Replimune Group Inc

NASDAQ:REPL   2:05:08 PM EDT
3.28
-2.44 (-42.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)255.65M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.63 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$5.34
50-Day MA$6.39
200-Day MA$9.69
See more pivots

Replimune Group Inc Stock, NASDAQ:REPL

500 Unicorn Park Drive, Suite 303, Woburn, Massachusetts 01801
United States of America
Phone: +1.781.222.9600
Number of Employees: 331

Description

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.